CENTRE LAB
Centre Lab is a French independent pharmaceutical CDMO in Guéret developing and manufacturing hospital preparations, clinical trial medications, contract-manufactured pharmaceuticals, cosmetics, and food supplements for hospitals, clinical trial sponsors, and pharma companies.
- Company typePrivate
- Founded1987
- HeadquartersGuéret, France
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What CENTRE LAB does
Centre Lab is an independent French pharmaceutical establishment founded in 1987 and headquartered in Guéret, Creuse, operating as a Contract Development and Manufacturing Organization (CDMO) under ANSM authorization. The company specializes in three core service lines: hospital preparations (small and medium production series in solid, semi-solid, and liquid forms for therapeutic needs unmet by commercial pharmaceuticals), clinical trial medication manufacturing (verums, placebos, blinding/randomization, and clinical batch production under arrêté du 24 mai 2006), and contract manufacturing (façonnage) with AMM support for non-sterile dry, liquid, and paste forms. Secondary revenue streams include MPUP (pharmaceutical raw materials), a four-product cosmetic line (Cérat Cosmétique, Pâte à l'eau, Cold Cream, Liniment Oléocalcaire), and food supplements. Customer segments are French hospitals and hospital pharmacies (PUI), clinical trial sponsors, and pharmaceutical companies seeking subcontracting services.
The company operates a 1,340 m² production site with three Class D controlled-atmosphere production lines (liquid, paste, solid), 230 m² of controlled-atmosphere storage, an integrated physico-chemical analysis laboratory (4 HPLC chains, UV spectrophotometer, TOC meter, conductimeter, pH meter, granulometer, titrator, dissolutest, disintegrator, densimeter), a microbiological analysis laboratory, and an R&D laboratory equipped with HPLC, GC-MS, ICH stability chambers, rotary evaporator, viscometer, and centrifuges for analytical method development, validation, and formulation work. Quality systems conform to BPF/GMP, ANSM pharmaceutical establishment authorization, ISO 13485, ISO 22716, ICH Q10, and EUDRA GMP frameworks.
Centre Lab generates revenue through project-based managed services and professional services contracts — pricing is not publicly disclosed and access to the professional portal requires RPPS registration. Go-to-market is enterprise field sales direct to hospitals, pharmacies, and clinical trial sponsors, complemented by a B2B professional portal, LinkedIn presence, and YouTube content. The company is founder/management-owned, led by two co-directors (Matthieu Fournier, Industrial Director; Gilles Ducret, Responsible Pharmacist and Director of QA/QC/Regulatory), and operates as part of a group network with Instel Chimos and Diver Chim for complementary manufacturing synergies. A 3,000 m² industrial extension at the Guéret site began construction on June 10, 2025, co-financed by the French state, Région Nouvelle-Aquitaine, Europe (France 2030), BPI France, BNP Paribas, Caisse d'Epargne, and Crédit Agricole — planned to nearly double headcount from 42 to over 80 employees.
CENTRE LAB firmographics
Firmographics- Name
- CENTRE LAB
- Legal name
- Centre Lab
- Website
- https://centre-lab.com
- Company type
- Private
- Founded year
- 1987
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Centre Lab is a French independent pharmaceutical CDMO in Guéret developing and manufacturing hospital preparations, clinical trial medications, contract-manufactured pharmaceuticals, cosmetics, and food supplements for hospitals, clinical trial sponsors, and pharma companies.
- Ownership category
- akta.pro rank
CENTRE LAB industry classification
Industry- Product category
- Pharmaceutical Contract Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Scientific Research and Development Services (5417)
- SIC
- Pharmaceutical Preparations (2834), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)
- akta.pro secondary industries
- Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK), CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD), GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL)
Keywords
Where CENTRE LAB is headquartered
LocationHeadquarters
- HQ city
- Guéret
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
CENTRE LAB business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Revenue model
- Hospital Preparations Manufacturing: Development and manufacturing of custom hospital preparations (préparations hospitalières) for healthcare facilities - small to medium production series
- Clinical Trial Medications: Development and manufacturing of experimental medications (médicaments expérimentaux) for clinical trials including verums, placebos, and clinical batch production with blinding and randomization services
- Contract Manufacturing (Façonnage): Subcontracting services for dry, liquid, and paste non-sterile forms including MA (marketing authorization) support
- MPUP, Cosmetics, and Supplements: Sale of pharmaceutical raw materials (matières premières à usage pharmaceutique), cosmetic products (Cérat Cosmétique, Pâte à l'eau, Cold Cream, Liniment Oléocalcaire), and food supplements
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
CENTRE LAB product offering
Product offeringCore offering
CENTRE LAB is an independent French pharmaceutical Contract Development and Manufacturing Organization (CDMO) that develops and manufactures hospital preparations, experimental medications for clinical trials (verums, placebos), contract manufacturing (façonnage) services with AMM support for dry/liquid/paste non-sterile forms, and produces pharmaceutical raw materials (MPUP), cosmetics, and food supplements. The company operates from a 1,340 m² ANSM-authorized, BPF-certified site in Guéret, France with three Class D controlled-atmosphere production lines and integrated analytical and R&D laboratories.
Product overview
Centre Lab is an independent French pharmaceutical CDMO (Contract Development and Manufacturing Organization) offering a unified portfolio of hospital preparations, clinical trials services, and contract manufacturing for pharmaceuticals, cosmetics, and food supplements. The core offerings include: hospital preparations (solid, semi-solid, and liquid forms) for when commercial products are unavailable; clinical trial support with experimental drug development, placebo/verum formulation, and regulatory compliance; and contract manufacturing/subcontracting with AMM services. Centre Lab also provides a line of 4 cosmetic products (Cérat Cosmétique, Pâte à l'eau, Cold Cream, Liniment Oléocalcaire) and offers R&D and quality control services supported by their 1340m2 production facility with 3 controlled-atmosphere production lines.
Differentiator
Problem solved
Functional benefit
Products and services
- Préparations Hospitalières (Hospital Preparations) Custom development and manufacturing of hospital preparations for healthcare facilities when commercial pharmaceutical specialties are unavailable or not marketed; small to medium production series in solid, semi-solid, and liquid forms. Target customers are hospitals and hospital pharmacies (PUI).
- Essais Cliniques (Clinical Trial Services) Development and manufacturing of experimental medications for clinical trials, including formulation of verums and placebos, clinical batch production, blinding and randomization services, and regulatory compliance support. Target customers are clinical trial sponsors.
- Façonnage et Sous-traitance AMM (Contract Manufacturing with Marketing Authorization Support) Contract manufacturing and subcontracting services for non-sterile dry, liquid, and paste forms including tablets, capsules, and powders, with AMM (marketing authorization) regulatory support. Target customers are pharmaceutical companies seeking small-batch production capabilities.
- MPUP, Cosmétiques et Compléments Alimentaires (Pharmaceutical Raw Materials, Cosmetics, Food Supplements) Production of pharmaceutical-grade raw materials (MPUP - matières premières à usage pharmaceutique), cosmetic product development and manufacturing, and food supplement production with custom formulation services. Target customers are cosmetic and supplement manufacturers.
- Cérat Cosmétique (Cosmetic Cerate) Cerate cosmetic product in Centre Lab's four-product cosmetic line, manufactured at the Guéret site.
- Pâte à l'eau (Water Paste) Water paste cosmetic product in Centre Lab's four-product cosmetic line, manufactured at the Guéret site.
- Cold Cream Cold cream cosmetic product in Centre Lab's four-product cosmetic line, manufactured at the Guéret site.
- Liniment Oléocalcaire (Lime and Oil Liniment) Lime and oil liniment cosmetic product in Centre Lab's four-product cosmetic line, manufactured at the Guéret site.
Companies that use CENTRE LAB
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles4 records
CENTRE LAB technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
CENTRE LAB partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered major, supporting and core.
- ADI Nouvelle AquitainemajorRegional development agency providing support for the 3,000m² extension project in Guéret, part of local economic development initiatives.
- Communauté d'Agglomération du Grand GuéretmajorLocal territorial authority supporting Centre Lab's expansion in the Guéret area as part of regional development.
- CCI CreusesupportingChamber of Commerce and Industry of Creuse supporting local business development.
- Ville de GuéretsupportingMunicipality of Guéret supporting Centre Lab's local expansion.
- Département de la CreusesupportingDepartmental authority supporting pharmaceutical manufacturing development in the Creuse region.
- Ingerop Maîtrise d'OeuvresupportingEngineering firm providing project management for the construction extension.
- Instel ChimoscoreGroup partner company within the pharmaceutical manufacturing network, providing synergies in product development and manufacturing capabilities.
- Diver ChimcoreGroup partner company within the pharmaceutical manufacturing network, providing complementary manufacturing and development capabilities.
Scale indicators7 records
Recent moves7 records
Expansion highlights5 records
CENTRE LAB competitors and assessment
Company assessmentDirect peers
- Delpharm: Largest French-headquartered CDMO with extensive non-sterile solid, liquid, and semi-solid manufacturing capabilities. Directly competes with Centre Lab in façonnage and contract manufacturing for French and European pharma clients across similar dosage forms.
- Hovione: Portugal-based CDMO with strong clinical trial materials, formulation development, and small-molecule manufacturing. Comparable in clinical trial verum/placebo manufacturing and small-to-mid-batch capability.
- Fareva: Major French CDMO with broad pharmaceutical, cosmetic, and active ingredient manufacturing. Overlaps directly with Centre Lab's façonnage, MPUP, and cosmetics businesses and shares the French B2B pharmaceutical customer base.
- Unither Pharmaceuticals: French CDMO specialized in unit-dose pharmaceutical forms and hospital preparations. Closely comparable mission (hospital preparations, small-batch manufacturing) and customer base (hospital pharmacies and clinical trial sponsors).
- Diverchim CDMO: French CDMO offering API and intermediate manufacturing with custom synthesis services. Comparable French-headquartered, independent CDMO serving similar pharmaceutical customers with complementary API/intermediate capabilities.
- Pharmatis: Independent French pharmaceutical manufacturer focused on liquid and semi-solid forms for hospital preparations and contract manufacturing. Closely aligned niche positioning and French regulatory footprint.
Broad incumbents
- Recipharm: European CDMO offering contract development and manufacturing across multiple dosage forms. Overlaps with Centre Lab's façonnage and clinical trial supply services but serves a much broader European customer base.
- Aenova: One of Europe's largest CDMOs with broad solid, semi-solid, and sterile capabilities. Competes with Centre Lab in solid dose contract manufacturing and AMM support but at meaningfully larger scale.
- Catalent: Global CDMO leader with extensive clinical trial supply, oral solid, and specialty manufacturing capabilities. Competes with Centre Lab in clinical trial materials and small-batch manufacturing as a much larger incumbent.
Emerging players
- Eurofins CDMO: European CDMO services arm of Eurofins offering contract development and manufacturing for pharma and biotech. Comparable in clinical trial and small-batch CDMO services with a growing European footprint.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
CENTRE LAB social profiles
Digital presenceCENTRE LAB compliance and trust
Trust signalCompliance6 records
CENTRE LAB financial estimates
Financial estimateRevenue estimate
Valuation estimate
CENTRE LAB leadership team
Management profileNumber of profiles
Profiles2 records
CENTRE LAB funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CENTRE LAB M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CENTRE LAB
What does CENTRE LAB do?
CENTRE LAB is an independent French pharmaceutical Contract Development and Manufacturing Organization (CDMO) that develops and manufactures hospital preparations, experimental medications for clinical trials (verums, placebos), contract manufacturing (façonnage) services with AMM support for dry/liquid/paste non-sterile forms, and produces pharmaceutical raw materials (MPUP), cosmetics, and food supplements. The company operates from a 1,340 m² ANSM-authorized, BPF-certified site in Guéret, France with three Class D controlled-atmosphere production lines and integrated analytical and R&D laboratories.
Is CENTRE LAB a public or private company?
CENTRE LAB is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was CENTRE LAB founded?
CENTRE LAB was founded in 1987. It employs 11 to 50 people.
Where is CENTRE LAB based?
CENTRE LAB is headquartered in Guéret, France, in the Europe region.
How does CENTRE LAB make money?
Four revenue lines are on record. Hospital Preparations Manufacturing is the primary driver. The others are clinical Trial Medications, contract Manufacturing (Façonnage) and MPUP, Cosmetics, and Supplements.
Who are CENTRE LAB's main competitors?
Direct peers on record are Delpharm, Hovione, Fareva, Unither Pharmaceuticals, Diverchim CDMO and Pharmatis. Broad incumbents are Recipharm, Aenova and Catalent. Eurofins CDMO is listed as an emerging player.
Does CENTRE LAB have an API?
No public API is recorded for CENTRE LAB.
What industry is CENTRE LAB in?
CENTRE LAB's product category is Pharmaceutical Contract Manufacturing. Its primary akta.pro industry code is HLAGABAB, Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO, with a secondary code of HLAGABAK, Clinical Trial Material (CTM) Manufacturing & Supply CDMO. Its NAICS code is 325412 and its SIC code is 2834.